PXE Updates
Research, Industry Developments & Patient Stories.
In the last 20 years, various treatment options have emerged for Pseudoxanthoma Elasticum (PXE). However, most of these seem outdated or not generally applicable. In this section, we reflect on the broad spectrum of treatment options and focus on the current clinical options, the latest developments, and future perspectives.
Living With PXE: What Patients Face and What Orfenix Is Doing About It
A rare disease with real impact—discover how PXE affects patients and what Orfenix is doing to help.
Ask ChatGPT
Therapy of Pseudoxanthoma Elasticum: Current Knowledge and Future Perspectives
In this review, researchers summarize the broad spectrum of treatment options for PXE, focusing on currently available clinical options, the latest research and development, and future perspectives. View the article
Pseudoxanthoma Elasticum resulting in acute coronary syndrome
In this article researchers describe a rare case of acute coronary syndrome in a PXE patient with high bleeding risk. View the article
ABCC6 Deficiency Promotes Development of Randall Plaque
Pseudoxanthoma elasticum (PXE) is a genetic disease caused by mutations in the ABCC6 gene that result in low pyrophosphate levels and subsequent progressive soft tissue calcifications. PXE mainly affects the skin, retina, and arteries. However, many patients with PXE...
Get in touch with someone local.
We are always ready to help. Whether you need support to get in touch with a Health Care professional or you want to talk to a peer, let us know. Leave us your details and we will be in touch soon.